secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spero Therapeutics, Inc. (SPRO)
CIK:        0001701108
Form:       8-K
Filed at:   2024-09-10T23:59:59+00:00
Accession:  0001193125-24-216310
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spero Therapeutics updates investor presentation; no material new financial or operational data disclosed
--------------------------------------------------------------------------------

- Filed an updated investor presentation dated September 9, 2024, under Regulation FD.
- Presentation available on Spero's IR website; company disclaims obligation to update after that date.
- No specific financial metrics, pipeline updates, or guidance changes were provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1701108/000119312524216310/0001193125-24-216310-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1701108/000119312524216310/d819424d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-216310

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer